In good times and bad, healthcare talent is hard to find. Agency demand for individuals with proven records of navigating the regulatory minefield of the FDA far exceeds supply. Clients are increasingly intolerant of inexperienced people working on their business, in any capacity. For healthcare companies, the risks of non-compliance are simply too high.
A study published in May by Rx Compliance Report asked drug and device company regulatory executives to assess risks and activities of their so-called “promotional agencies.” ...